Amirul Hafiz Ahmad Abdullah1, Hilal Haiqal Faizal1, Nurul Farhana Jufri1, Siti Fathiah Masre1, Nor Fadilah Rajab2, Hanafi Ahmad Damanhuri3, Farah Wahida Ibrahim1*
1. Center for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia
2. Center for Healthy Ageing and Wellness (H-CARE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, 50300 Kuala Lumpur, Malaysia
3. Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Kuala Lumpur, Malaysia
*Corresponding author: Farah Wahida Ibrahim.
ABSTRACT
INTRODUCTION: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive impairment and neurobiological changes, including amyloid plaque accumulation and alterations in cell death pathways such as pyroptosis. While many studies emphasize static endpoints, the temporal progression of AD-like pathology remains poorly understood.
OBJECTIVE(S): This study aimed to evaluate progressive memory impairment and identify pyroptosis-related molecular alterations across different durations of aluminium (Al) exposure in a rat model of AD.
MATERIALS & METHODS: To achieve this, adult male Wistar rats were administered aluminium chloride (AlCl3) at 200 mg/kg/day via oral gavage for 14, 28, and 42 days. Memory functions were assessed using the 2-novel object recognition (2NOR) test (non-spatial memory) and the Y-maze test (spatial memory). Following exposure, hippocampal tissues were collected for RNA sequencing. Transcriptomic data were analyzed using DESeq2, ViSEAGO, and gene set enrichment analysis (GSEA) to identify pathways associated with cognitive decline.
RESULTS: Results showed that both non-spatial and spatial memory were significantly impaired in all Al-exposed groups compared to controls (p<0.05). Transcriptomic profiling revealed progressive enrichment of AD-associated pathways, particularly those related to amyloid fibril formation, amyloid-β clearance, and pyroptosis. Among the pyroptosis-related genes, Caspase-1 and Gasdermin D were notably upregulated in a time-dependent manner. These findings suggest that the activation of pyroptotic signalling may contribute to, or reflect, the observed cognitive deficits in Al-induced neurodegeneration.
CONCLUSION: This study demonstrates that progressive memory impairment in an Al-induced AD model parallels the upregulation of pyroptosis-related genes. The temporal association between behavioural decline and inflammatory molecular changes highlights pyroptosis as a potential contributor and biomarker in AD-like pathology. Future studies will include Western blotting to validate pyroptosis-related protein expression and further clarify its role in disease progression.
KEYWORDS: Alzheimer’s Disease, Pyroptosis, Cognitive Impairment, Transcriptomics


